[Cheng Yeh Medical] February 2026 Revenue Reaches NT$269 Million (YOY +22.8%)
Cheng Yeh Medical (4164), a leading provider of radiotherapy oncology equipment and services, announced strong revenue performance for February 2026. The company's monthly revenue reached NT$269 million, representing a year-on-year increase of 22.8%. This growth reflects the stable recognition of equipment installation and service contracts with hospital clients, demonstrating its leadership position in the high-end medical market.
📋 Article Processing Timeline
- 📰 Published: February 1, 2026 at 09:00
- 🔍 Collected: April 7, 2026 at 08:00 (1559h 0m after Published)
- 🤖 AI Analyzed: April 8, 2026 at 00:19 (16h 19m after Collected)
Company Code: 4164
Company Name: Cheng Yeh Medical
Industry: Biotechnology and Medical Industry
Data Month/Year: 2026-02
Current Month Revenue: NT$268,691 thousand (NT$269 million)
Year-on-year change from same month last year: +22.8%
Company Name: Cheng Yeh Medical
Industry: Biotechnology and Medical Industry
Data Month/Year: 2026-02
Current Month Revenue: NT$268,691 thousand (NT$269 million)
Year-on-year change from same month last year: +22.8%